Tokat, F. Et Al. 2018. Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.. Dermatology practical & conceptual , vol.8 , 28-32.

Tokat, F., Lehman, J., Sezer, E., Cetin, E., Ince, Ü., & Durmaz, E., (2018). Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.. Dermatology practical & conceptual , vol.8, 28-32.

Tokat, Fatma Et Al. "Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.," Dermatology practical & conceptual , vol.8, 28-32, 2018

Tokat, Fatma Et Al. "Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.." Dermatology practical & conceptual , vol.8, pp.28-32, 2018

Tokat, F. Et Al. (2018) . "Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.." Dermatology practical & conceptual , vol.8, pp.28-32.

@article{article, author={Fatma TOKAT Et Al. }, title={Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.}, journal={Dermatology practical & conceptual}, year=2018, pages={28-32} }